4^th International Conference on Blood Malignancies and Treatment April 18-19, 2016 Dubai,UAE

OMICS International is glad to welcome all the interested participants to its 4^th International Conference on Blood Malignancies and Treatment during April 18-19, 2016 at Dubai, UAE. The conference will be organized around the theme “Conquering blood cancer with contemporary precision therapeutics and restorative approaches”. Blood Cancer 2016 welcomes the hematologists, immunologists, pathologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of it.

Blood Cancer 2016 will be an initiative to find the weapon to fight against the dreadful blood cancers, to protect and save lives. Discussions will be focused on the different types of blood cancers, possibility of early detection and treatment at the advanced stages of these cancers to prolong life.

Track 1: Blood Malignancies

Blood malignancies are forms of cancer that begins in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system. Examples of hematologic cancer are acute and chronic leukaemia, lymphomas, multiple myeloma and myelodysplastic syndromes. Myeloproliferative neoplasms, or MPNs, are hematologic cancers that arise from malignant hematopoietic myeloid progenitor cells in the bone marrow, such as the precursor cells of red cells, platelets and granulocytes. The other types of Blood Malignancies also include sarcoma, lymphodema, Non-Hodgkin lymphoma (NHL) and lymphoma, lymphoid cancer, bone marrow cancer.

Related Conferences : ASH meeting 2016 ; 4^th International Conference on Blood Malignancies & Treatment April 18-20 2016,UAE ; 5^th International Conference on Haemophilia June 06-08 2016,UK ; International Conference on Leukemia and Bone marrow Transplantation Nov 10-12 2016, Turkey ; 8^th Euro Global Summit on Cancer Therapy November 03-05 2015,Spain; 10^th Global Annual Oncologists Meeting July 11-13 2016, Germany ;6^th International Conference on Hematology and Lymph Nov 14-16, 2016 ,USA; Global Summit & Expo on Health care November 9-11 2015,UAE ; International Conference on Internal Medicine November 03-05, 2016 ,USA ;Spring to life conference on haematological disorders April 16 2016, USA ; 18th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy, Sep 15 - 18, 2016, US; The 26^th Regional congress of the ISBT  November 14-16 2015, Indonesia ; Texas Bleeding Disorders Conference November 8 2015 ,Texas ; Euro thrombosis Summit 2015 Oct 1-3 2015,Como ; ASH Meeting on Hematologic Malignancies Sep 17-19 2015,USA; 7th International Hematologic Malignancies Conference: Bridging the Gap February 27-28, 2016, China; 14th International Conference on Malignant Lymphoma, Jun 14-17,2016; 6th ESMO Sarcoma & GIST Conference, 16-17 February 2016, Italy; International Conference on Aging and Hematological Malignancies: Biology and Therapy ,March 11 - March 13, 2016, Greece; 2nd International Conference on New Concepts in B-Cell Malignancies, September 09 - 11, 2016, Portugal ; International Conference on Hematological Malignancies ;12^th Cancer Conferences Europe September 26-28, 2016 London, UK;12^th Oncology Conferences Europe September 26-28, 2016 London, UK; 12^th Cancer Science Events Europe September 26-28, 2016 London, UK;  Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE;  Oncology Conferences November 21-23, 2016 Dubai, UAE;  Worldwide Cancer Events November 21-23, 2016 Dubai, UAE;  Breast Cancer Conferences October 03-05, 2016 London, UK;  Women’s Health Conferences October 03-05, 2016 London, UK

Track 2: Leukeamia

Leukemia is a group of cancers that usually begin in the bone marrow and result in high numbers of abnormal white blood cells. These white blood cells are not fully developed and are called blasts or leukemia cells. Different kinds of leukemia are believed to have different causes. There are four main types of leukemia — acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML).Leukemias and lymphomas both belong to a broader group of tumors that affect the blood, bone marrow, and lymphoid system, known as tumors of the hematopoietic and lymphoid tissues. It is the most common type of cancer in children, with three quarters of leukemia cases in children being ALL

Related Conferences :4^th International Conference on Blood Malignancies & Treatment April 18-20 2016,UAE ; LLS Blood Cancer Conference ; Children Vaccines Conference 2016 Oct 10-12, 2016 Rome, Italy ; International Conference on Leukemia and Bone marrow Transplantation Nov 10-12 2016, Turkey  ; 5^th International Conference on haemophilia  June 06-08 2016, UK ; 10^th Global Annual Oncologists Meeting July 11-13 2016, Germany ; 7^th International conference on Biomarkers & Clinical Research November 28-30 2016,USA; 6^th International Conference on Hematology and Lymph Nov 14-16, 2016; ; 7^th International Conference on Biomarkers and Clinical Research, November 28-30, 2016, USA ;5th International Conference and Exhibition on Pathology ,May 09-11, 2016, USA ;17th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy, October 01 -, 2015, Portugal;Advances in Paediatric Cancer Research: From Mechanisms and Models to Treatment and Survivorship November 9-12 2015, Florida ; Childhood Cancer 2016  April 24 2016,London ; Blood Cancer Conference ; Lymphoma Oct 6 2015,London ; 5th  Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin’s Lymphoma Oct 22-24 2015, Italy; 18th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy, Sep 15 - 18, 2016,USA; The 15th International Conference on Progress in Vaccination Against Cancer, 6-8^th October, 2015, Germany; Hematological Malignancies Review ; WSMOS Fall Oncology Conference, 30^th October 2015,UK; Mayo Clinic Acute and Chronic Leukemias 2016: A Case Based Discussion, September 2016,AZ, USA; Blood Cancer Conference ;12^th Cancer Conferences Europe September 26-28, 2016 London, UK;12^th Oncology Conferences Europe September 26-28, 2016 London, UK; 12^th Cancer Science Events Europe September 26-28, 2016 London, UK;  Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE;  Oncology Conferences November 21-23, 2016 Dubai, UAE;  Worldwide Cancer Events November 21-23, 2016 Dubai, UAE;  Breast Cancer Conferences October 03-05, 2016 London, UK;  Women’s Health Conferences October 03-05, 2016 London, UK

Track 3: Myeloma

Myeloma is a cancer arising from plasma cells, a type of white blood cell which is made in the bone marrow. Unlike many cancers, myeloma does not exist as a lump or tumour. Myeloma can be of smoldering type & the common known as multiple myeloma. Myeloma affects multiple places in the body (hence ‘multiple’ myeloma) where bone marrow is normally active in an adult i.e. within the bones of the spine, skull, pelvis, the rib cage, long bones of the arms and legs and the areas around the shoulders and hips. Myeloma is a relapsing-remitting cancer.

Related Conferences : 4^th International Conference on Blood Malignancies & Treatment April 18-20 2016,UAE ;International Conference on Transplantation Research March 28-29 2016 ,USA ; 6^th International Conference on Hematology and Lymph Nov 14-16, 2016 ,USA ; ASH Conference 2016 ;International Conference on Leukemia and Bone marrow Transplantation Nov 10-12 2016, Turkey ; 9th Indo Global Summit on Cancer Therapy, November 02-04, 2015 Hyderabad, India; ASH Hematology Abstracts ; 10^th Global Annual Oncologists Meeting July 11-13 2016, Germany; 7^th International conference on Biomarkers & Clinical Research November 28-30 2016,USA ; 8^th Euro Global Summit on Cancer Therapy November 03-05 2015,Spain;16th International Workshop on Chronic Lymphocytic Leukaemia 2015, Australia ; BMT Tandem Meetings February 18 - 22 2016, US ; 56^th Annual meeting of the Indian Society of Hematology and Blood Transfusion Nov 5-8 2015, India ; BBTS Annual Conference 2016 21st - 23rd September 2016, Harrogate ; 2015 ANNUAL MEETING on medical oncology Oct 9-13 2015,Basel; Regulatory Myeloid Stem Cells Conference,16–19 June 2016,Philadelphia, United States; Blood Cancer Survivorship Conference: Moving Beyond Cancer Treatments, USA; 3rd International Conference on Multiple Myeloma, October 07-09, 2016, Italy; ISEH 45th Annual Scientific Meeting 2016 August 25-28, 2016, USA; Cancer Diagnostics Conference; San Francisco Nov 16-17 2015 , United States;12^th Cancer Conferences Europe September 26-28, 2016 London, UK;12^th Oncology Conferences Europe September 26-28, 2016 London, UK; 12^th Cancer Science Events Europe September 26-28, 2016 London, UK;  Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE;  Oncology Conferences November 21-23, 2016 Dubai, UAE;  Worldwide Cancer Events November 21-23, 2016 Dubai, UAE;  Breast Cancer Conferences October 03-05, 2016 London, UK;  Women’s Health Conferences October 03-05, 2016 London, UK

Track 4: Myelodysplastic Syndrome

The myelodysplastic syndromes (also known as MDS or myelodysplasia) are haematological medical conditions with ineffective production of all blood cells. In some cases, the disease worsens and the patient develops low blood counts caused by progressive bone marrow failure. The myelodysplastic syndromes are all disorders of the hematopoietic stem cells in the bone marrow. In MDS, blood production is disorderly and ineffective. The number and quality of blood-forming cells decline irreversibly, further impairing blood production. In this section detailed information about myelodysplastic syndromes will be discussed.

Related Conferences :4^th International Conference on Blood Malignancies & Treatment April 18-20 2016,UAE ; LLS Blood Cancer Conference ; 3^rd  International conference on Hematology & Blood Disorders November 2-4 2015,USA ; 6^th International Conference on Hematology and Lymph Nov 14-16, 2016 ,USA; International Conference on Internal Medicine November 03-05, 2016 ,USA ; 11^th Asia Pacific Oncologists Conference, July 11-13, 2016, Malaysia; Cancer Diagnostics Conference and Expo, June 13-15, 2016, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA ; 5th International Conference and Exhibition on Pathology May 09-11, 2016, USA; 5^th International Conference on Haemophilia June 06-08 2016,UK; World Cord Blood Congress Europe May21-22 2016 ,London ; 2016 Annual Meeting and Exposition May 15 – 18 2016, Louisiana ; 42^nd Annual Meeting of blood & Bone Marrow Transplantation Apr 3 -6 2016, Spain ; American Association of Blood Banks Annual Meeting & CTTXPO 2015 October 24-27 2015, CA ; 20^th International Congress on Hematological Malignancies, March 18 – 20 2016,FL; 5th International Conference on Myelodysplastic Syndromes, April 14 - April 16, 2016, Portugal; Cancer and Metabolism September 28 - 30, 2015,UK; BSG Conference 2016, 3 Feb-5 Feb2016,UK; New and Emerging Trends In Oncology 2016,10 Feb-12 Feb 2016,Hyderabad, India; Controlling Cancer Summit 17 -19 May 2016, UK; International Conference on Hematological Malignancies;12^th Cancer Conferences Europe September 26-28, 2016 London, UK;12^th Oncology Conferences Europe September 26-28, 2016 London, UK; 12^th Cancer Science Events Europe September 26-28, 2016 London, UK;  Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE;  Oncology Conferences November 21-23, 2016 Dubai, UAE;  Worldwide Cancer Events November 21-23, 2016 Dubai, UAE;  Breast Cancer Conferences October 03-05, 2016 London, UK;  Women’s Health Conferences October 03-05, 2016 London, UK 

Track 5: Childhood Hematological Cancers

Childhood blood cancers are rare. The major subtypes of childhood blood cancers are lymphoblastic, Burkitt, large B cell & anaplastic large cell. Treatment at special centres for children and teens provides the advantages of specialized care. In addition, childhood cancers tend to respond to treatment better than adult cancers do, and children's bodies often tolerate treatment better. Treatment may involve antibiotics, blood transfusions, or other measures to fight infection. In this section, we will be discussing about the various types of childhood blood cancers, symptoms included, their diagnosis & treatment options available.

Related Conferences : 4^th International Conference on Blood Malignancies & Treatment April 18-20 2016,UAE ; 3^rd International conference on Hematology & Blood Disorders November 2-4 2015,USA ;  Blood Cancer Conference  ; International Conference on Leukemia and Bone marrow Transplantation Nov 10-12 2016, Turkey ; 6^th International Conference on Hematology and Lymph Nov 14-16, 2016;10^th Global Annual Oncologists Meeting July 11-13 2016, Germany ;Children Vaccines Conference 2016 Oct 10-12, 2016 Rome, Italy; International Conference on Internal Medicine November 03-05, 2016,USA; 7^th International conference on Biomarkers & Clinical Research November 28-30 2016,USA ; 8^th Euro Global Summit on Cancer Therapy November 03-05 2015,Spain;Advances in Paediatric Cancer Research: From Mechanisms and Models to Treatment and Survivorship November 9-12 2015, Florida; Childhood Cancer 2016  April 24 2016,London;SIOP 2015 Congress Oct 8-9 2015, South Africa; ASH Conference : Lymphoma Oct 6 2015,London;5th  Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin’s Lymphoma Oct 22-24 2015, Italy; SIOPE 4th Paediatric Oncology Conference20 -21 Jan 2016, Belgium; Mayo Clinic Acute and Chronic Leukemias 2016: A Case Based Discussion, September 2016,USA; 2017 ASCO Annual Meeting, June 2-6 ,2016 USA; Stem Cell Summit,25–27 April 2016,Boston, USA; Cancer and Metabolism September 28 - 30, 2015,UK; ASH meeting 2016;12^th Cancer Conferences Europe September 26-28, 2016 London, UK;12^th Oncology Conferences Europe September 26-28, 2016 London, UK; 12^th Cancer Science Events Europe September 26-28, 2016 London, UK;  Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE;  Oncology Conferences November 21-23, 2016 Dubai, UAE;  Worldwide Cancer Events November 21-23, 2016 Dubai, UAE;  Breast Cancer Conferences October 03-05, 2016 London, UK;  Women’s Health Conferences October 03-05, 2016 London, UK

Track 6: Blood Cancer: Diagnosis

To confirm the presence of cancer and the severity or the stages of the cancer various cancer detection tests are carried out; certain cancer blood tests or other laboratory tests, such as an analysis of your urine or a biopsy of a suspicious area, to help guide the diagnosis. With the exception of blood cancers, blood tests generally can't absolutely tell cancer or some other noncancerous condition, but they can give your doctor the clues about what's going on inside the body. The other kind of tests performed to diagnose or confirm blood cancer can also include complete blood count and Blood protein testing, Tumour marker tests and Biopsy, Cytogenetic, Imaging and Radiation Oncology, Endoscopy.

Related Conferences :Cancer Diagnostics Conference & Expo June 13-15 2016,Italy ; International Conference on Internal Medicine November 03-05, 2016 ,USA ; 4^th International Conference on Blood Malignancies & Treatment April 18-20 2016,UAE ; 3^rd International conference on Hematology & Blood Disorders November 2-4 2015,USA ; International Conference on Leukemia and Bone marrow Transplantation Nov 10-12 2016, Turkey ; 7^th International conference on Biomarkers & Clinical Research November 28-30 2016,USA ; 8^th Euro Global Summit on Cancer Therapy November 03-05 2015,Spain; 9th Indo Global Summit on Cancer Therapy, November 02-04, 2015 Hyderabad, India; Children Vaccines Conference 2016 Oct 10-12, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016, USA; Cancer Genome February 7-11, 2016; VI Inter American Oncology Conference 'Current Status and Future of Therapies’, October 8-9^th, 2015;Fourth AACR International Conference on Frontiers in Basic Cancer Research October 23 – 26 2015,Philadelphia ; 2015 Chabner Colloquium: Collaboration in Cancer Drug Trials 26–27 October 2015, United States ; American Society for Clinical Pathology Annual Meeting Oct 28-30 ,USA ; SITC’s 30th Anniversary Annual Meeting & Associated Programs November 4 – 8, 2015,US ; Cancer Diagnostics Conference; San Francisco Nov 16-17 2015 , United States; Cancer and Metabolism September 28 - 30, 2015,UK; Stem Cell Research & Regenerative Medicine Conference,25–26 April 2016,USA;12^th Cancer Conferences Europe September 26-28, 2016 London, UK;12^th Oncology Conferences Europe September 26-28, 2016 London, UK; 12^th Cancer Science Events Europe September 26-28, 2016 London, UK;  Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE;  Oncology Conferences November 21-23, 2016 Dubai, UAE;  Worldwide Cancer Events November 21-23, 2016 Dubai, UAE;  Breast Cancer Conferences October 03-05, 2016 London, UK;  Women’s Health Conferences October 03-05, 2016 London, UK

Track 7: Blood Cancer : Causes & Symptoms

The cause is usually different from other types of cancer. Experts say that Blood Malignancies arise due to different causes, some of them are suspected and some are yet to be. It is nearly impossible to prove what caused a blood cancer in any individual, because most blood cancers have multiple possible causes.

Discussions will be carried out on the suspecting and suspected causes of blood cancer that include: Exposure to radiation and chemicals, Genetic predisposition, drugs, Human T-cell Leukemia Virus (HTLV), Electromagnetic energy, Genetic factors (chromosomal abnormalities, maternal fetal transmission (rare).

Related Conferences : Cancer Diagnostics Conference and Expo, June 13-15, 2016, Italy; 4^th International Conference on Blood Malignancies & Treatment April 18-20 2016,UAE ; International Conference on Leukemia and Bone marrow Transplantation Nov 10-12 2016, Turkey ; LLS Blood Cancer Conference ;10^th Global Annual Oncologists Meeting July 11-13 2016, Germany International Conference on Internal Medicine November 03-05, 2016,USA; 7^th International conference on Biomarkers & Clinical Research November 28-30 2016,USA ; 8^th Euro Global Summit on Cancer Therapy November 03-05 2015,Spain; 7^th International Conference on Biomarkers and Clinical Research, November 28-30, 2016, USA;5th International Conference and Exhibition on Pathology May 09-11, 2016, USA; WSMOS Fall Oncology Conference, 30^th October 2015,UK; 7th International Hematologic Malignancies Conference: Bridging the Gap February 27-28, 2016, China; ISEH 45th Annual Scientific Meeting 2016 August 25-28, 2016,USA; Cancer Immunotherapy: Immunity and Immunosuppression Meet Targeted Therapies ,Jan 24-28, 2016,Canada; ASH Conference ; Controlling Cancer Summit 2016,17 May-19 May 2016,London, UK; Euro thrombosis Summit 2015 Oct 1-3 2015,Como ; ASH Meeting on Hematologic Malignancies  Sep 17-19 2015,USA; NCCN 21st Annual Conference: Advancing the Standard of Cancer Care March 31-April 2 2015, USA ; Second Annual New Treatments in Oncology March 5 2016, USA; Blood Cancer Conference;12^th Cancer Conferences Europe September 26-28, 2016 London, UK;12^th Oncology Conferences Europe September 26-28, 2016 London, UK; 12^th Cancer Science Events Europe September 26-28, 2016 London, UK;  Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE;  Oncology Conferences November 21-23, 2016 Dubai, UAE;  Worldwide Cancer Events November 21-23, 2016 Dubai, UAE;  Breast Cancer Conferences October 03-05, 2016 London, UK;  Women’s Health Conferences October 03-05, 2016 London, UK 

Track 8: Blood Cancer: Staging

Staging is the process of determining the extent to which a cancer has developed by spreading. Contemporary practice is to assign a number from I-IV to a blood cancer, with I being an isolated cancer and IV being a cancer which has spread to the limit of what the assessment measures. The stage generally takes into account the size of a tumor, whether it has invaded adjacent organs, how many regions it has spread to, and whether it has appeared in more distant locations .There are different yards sticks to distinguish blood cancer into different stages according to the symptoms of prognosis and rate of metastasis. In this section discussions will be carried out on different stages of various blood cancers.

Related Conferences :International conference on Molecular & Cancer Biomarkers September 15-17 2016 , Germany ; 7^th  International conference on Biomarkers & Clinical Research November 28-30 2016,USA ; 8^th Euro Global Summit on Cancer Therapy November 03-05 2015,Spain ; 4^th International Conference on Blood Malignancies & Treatment April 18-20 2016,UAE 5^th International Conference on haemophilia  June 06-08 2016, UK; 6^th International Conference on Hematology and Lymph Nov 14-16, 2016;10^th Global Annual Oncologists Meeting July 11-13 2016, Germany ;Children Vaccines Conference 2016 Oct 10-12, 2016 Rome, Italy; International Conference on Internal Medicine November 03-05, 2016,USA; 9th Indo Global Summit on Cancer Therapy, November 02-04, 2015,India; 11^th Asia Pacific Oncologists Conference, July 11-13, 2016, Malaysia; 7th International Hematologic Malignancies Conference: Bridging the Gap February 27-28, 2016, China; 14th International Conference on Malignant Lymphoma, Jun 14-17,2016; 6th ESMO Sarcoma & GIST Conference, 16-17 February 2016, Italy; International Conference on Aging and Hematological Malignancies: Biology and Therapy ,March 11 - March 13, 2016, Greece; 2nd International Conference on New Concepts in B-Cell Malignancies, September 09 - 11, 2016, Portugal; New Frontiers in Understanding Tumour Metabolism Feb 21-25, Canada ; Personalized Medicine World Conference Jan 26-29 2016, United States ; Combination Therapies in Cancer Conference: Tools and Techniques for Developing Combinations More Efficiently Dec 06- 09 2015, UK; Fourth AACR International Conference on Frontiers in Basic Cancer Research October 23 – 26 2015,USA; Congress of the International Society of Paediatric Oncology Oct 8-9 2015, South Africa; Blood Cancer Conference ;12^th Cancer Conferences Europe September 26-28, 2016 London, UK;12^th Oncology Conferences Europe September 26-28, 2016 London, UK; 12^th Cancer Science Events Europe September 26-28, 2016 London, UK;  Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE;  Oncology Conferences November 21-23, 2016 Dubai, UAE;  Worldwide Cancer Events November 21-23, 2016 Dubai, UAE;  Breast Cancer Conferences October 03-05, 2016 London, UK;  Women’s Health Conferences October 03-05, 2016 London, UK

Track 9: Blood Cancer: Treatment and Care

Treatment depends on many factors, including the type of cancer; age; how fast the cancer is progressing; where the cancer has spread; the symptoms and other health conditions. According to one of the most recent findings, researchers have come up with a curative alternative to blood cancer. The medication seeks to block the release of irregular enzymes accountable for the metastasis of blood cancer that are various therapies. Surfeit of protein accountable for the enlargement and increase of cancerous cells are likely to be blocked as well by the researched medication.

Different types of therapies such as Biological Therapy, Chemotherapy, Radiation Therapy, Bone Marrow Transplantation,
Stem Cell Transplantation, Targeted Therapy, Watchful Waiting,  Clinical medicine and anticancer drugs, Gene therapy and Stem cells therapy will be discussed in this scientific session.

Related Conferences :10^th Global Annual Oncologists Meeting July 11-13 2016, Germany ; 4^th International Conference on Blood Malignancies & Treatment April 18-20 2016,UAE  ;5^th International Conference on Haemophilia  June 06-08 2016, UK ; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016, Malaysia ; International Conference on Leukemia and Bone marrow Transplantation Nov 10-12 2016, Turkey; Conference on Surgical Oncology, September 01-03, 2016, Brazil; International Conference on Internal Medicine November 03-05, 2016,USA; Oncology Conference: Current Status and Future of Anti-Cancer Targeted Therapies October 8- 9 2015, Argentina ; NCCN 21st Annual Conference: Advancing the Standard of Cancer Care March 31-April 2 2015, USA ; Second Annual New Treatments in Oncology March 5 2016, AZ ; Controlling Cancer Summit 2016 May 17-19, United Kingdom ; 20th World Congress on Advances in Oncology, October 8-10 2015,Greece; Blood Cancer Survivorship Conference: Moving Beyond Cancer Treatments, USA; 2nd International Conference on New Concepts in B-Cell Malignancies, September 09 - 11, 2016, Portugal; Stem Cells and Cancer,06 Mar -10 Mar 2016,USA;New and Emerging Trends In Oncology 2016,10 Feb-12 Feb 2016, India; Controlling Cancer Summit 2016,17 May-19 May 2016,London, UK;12^th Cancer Conferences Europe September 26-28, 2016 London, UK;12^th Oncology Conferences Europe September 26-28, 2016 London, UK; 12^th Cancer Science Events Europe September 26-28, 2016 London, UK;  Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE;  Oncology Conferences November 21-23, 2016 Dubai, UAE;  Worldwide Cancer Events November 21-23, 2016 Dubai, UAE;  Breast Cancer Conferences October 03-05, 2016 London, UK;  Women’s Health Conferences October 03-05, 2016 London, UK

Track 10: Bone Marrow Transplantation & Surgery

A bone marrow transplant is a procedure to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Bone marrow is the soft, fatty tissue inside your bones. Stem cells are immature cells in the bone marrow that give rise to all of your blood cells. A biopsy is a sample of tissue taken from the body in order to examine it more closely. A doctor should recommend a biopsy when an initial test suggests that an area of tissue in the body isn't normal. Doctors may call that area of abnormal tissue a lesion, a tumour, or a mass.Topics of discussion in the scientific sessions are Bone Marrow Surgery, Stem Cell Surgery, Hematopoietic Cell Transplantations

Related Conferences : Blood Cancer Conference ; 4^th International Conference on Blood Malignancies & Treatment April 18-20 2016,UAE;5^th  International Conference on haemophilia  June 06-08 2016, UK; International Conference on Leukemia and Bone marrow Transplantation Nov 10-12 2016, Turkey; Global Summit & Expo on Health care November 9-11 2015,UAE;  6^th International Conference on Hematology and Lymph Nov 14-16, 2016;10^th Global Annual Oncologists Meeting July 11-13 2016, Germany Children Vaccines Conference 2016 Oct 10-12, 2016 Rome, ItalyInternational Conference on Internal Medicine November 03-05, 2016,USA; 7^th International conference on Biomarkers & Clinical Research November 28-30 2016,USA ; Spring to life conference on Hematological disorders April 16 2016, USA; The 26^th Regional congress of the ISBT  November 14-16 2015, Indonesia; Texas Bleeding Disorders Conference November 8 2015 ,Texas; Euro thrombosis Summit 2015 Oct 1-3 2015,Como;ASH Meeting on Hematologic Malignancies  Sep 17-19 2015,USA; Stem Cell Summit,25–27 April 2016,Boston, USA; Stem Cell Research & Regenerative Medicine Conference,25–26 April 2016,USA;Regulatory Myeloid Suppressor Cells Conference,16–19 June 2016,USA; ; Fourth AACR International Conference on Frontiers in Basic Cancer Research October 23 – 26 2015,USA; Congress of the International Society of Paediatric Oncology Oct 8-9 2015, South Africa;12^th Cancer Conferences Europe September 26-28, 2016 London, UK;12^th Oncology Conferences Europe September 26-28, 2016 London, UK; 12^th Cancer Science Events Europe September 26-28, 2016 London, UK;  Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE;  Oncology Conferences November 21-23, 2016 Dubai, UAE;  Worldwide Cancer Events November 21-23, 2016 Dubai, UAE;  Breast Cancer Conferences October 03-05, 2016 London, UK;  Women’s Health Conferences October 03-05, 2016 London, UK

Track 11:  Immunology of Blood Cancer

Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells (also called tumors or malignancies). It is a growing field of research that aims to discover innovative cancer immunotherapies to treat and retard progression of the disease. The immune response, including the recognition of cancer-specific antigens, is of particular interest in the field as knowledge gained drives the development of targeted therapy (such as new vaccines and antibody therapies) and tumour marker-based diagnostic tests. These scientific sessions will include the discussion on various topics such as Immunotherapeutic approaches, immune tolerance and deficiencies, Anti-Blood Cancer Factor and immunotherapy.

Related Conferences :8^th Euro Global Summit on Cancer Therapy November 03-05 2015,Spain ; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07 2016, USA ; International Conference on Internal Medicine November 03-05, 2016 ,USA ; 5^th  International Conference on Haemophilia  June 06-08 2016, UK ; 4^th International Conference on Blood Malignancies & Treatment April 18-20 2016,UAE ; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016, USA; 7^th International Conference on Biomarkers and Clinical Research, November 28-30, 2016, USA; 10^th Global Annual Oncologists Meeting July 11-13 2016, Germany ; Blood Cancer Conference ; Children Vaccines Conference 2016 Oct 10-12, 2016 Rome, Italy;20th World Congress on Advances in Oncology, October 8-10 2015,Greec e; ESMO Symposium on Immuno-Oncology Nov 20 - 21 2015, Switzerland  ; ASH Meeting on Lymphoma Biology June 18-21 2016,Colorado  ; IPFA/BCA 2nd Global Symposium on The future of Blood & Plasma Donations Sep 28-29 2015, USA ; SITS workshop on Advances In Cancer Immunotherapy Nov 18, USA; Cancer Immunotherapy: Immunity and Immunosuppression Meet Targeted Therapies ,Jan 24-28, 2016,Canada; Advances in Cancer Immunotherapy, Nov18,USA; Cancer Vaccines: Targeting Cancer Genes for Immunotherapy, March 6-10, 2016, Canada; The 15th International Conference on Progress in Vaccination Against Cancer, 6-8^th October, 2015, Germany; Controlling Cancer Summit 2016,17 May-19 May 2016,London, United Kingdom;12^th Cancer Conferences Europe September 26-28, 2016 London, UK;12^th Oncology Conferences Europe September 26-28, 2016 London, UK; 12^th Cancer Science Events Europe September 26-28, 2016 London, UK;  Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE;  Oncology Conferences November 21-23, 2016 Dubai, UAE;  Worldwide Cancer Events November 21-23, 2016 Dubai, UAE;  Breast Cancer Conferences October 03-05, 2016 London, UK;  Women’s Health Conferences October 03-05, 2016 London, UK

Track 12: Blood Oncology

Many Advanced approaches to treat patients with blood cancer. Developments in personalized treatment are taken into account the type, location, and stage of the disease as well as the patient's age and physical health. Chemotherapy is the primary treatment for blood cancer, though some patients receive radiation therapy as well and/or a transplant of stem cells or bone marrow. According to studies, antioxidants like lymohotoxins can also reduce the risk of one suffering from Blood Malignancies.

Major discussions will be carried out on Molecular Pathogenesis and Personalized Treatment, Epidemiology of Blood Cancer ,Blood Cancer Awareness and Society, Alternate Cancer therapy, Prevention of blood cancer, Importance of Antioxidants.      

Related Conferences : 6^th International Conference on Cell & Stem Cell Research, Feb 29-March 02 2016, USA ; International Conference on Internal Medicine November 03-05, 2016 ,USA ; 4^thInternational Conference on Blood Malignancies & Treatment April 18-20 2016,UAE; Blood Cancer Conference  ; International Conference on Leukemia and Bone marrow Transplantation Nov 10-12 2016, Turkey ; 6^th International Conference on Hematology and Lymph Nov 14-16, 2016;10^th Global Annual Oncologists Meeting July 11-13 2016, Germany ;International Conference on Internal Medicine November 03-05, 2016,USA; 7^th International conference on Biomarkers & Clinical Research November 28-30 2016,USA ; 8^th Euro Global Summit on Cancer Therapy November 03-05 2015,Spain; EMBL Stem Cells Conference 2016  Jun 3 - 5  2016,Germany ; 20^th International Congress on Hematological Malignancies, March 18 – 20 2016,FL ; Conference on Myeloma & Lymphoma October 2015,New York ; ASH Meeting on Hematologic Malignancies  Sep 17-19 2015,USA ; NCCN 10th Annual Congress: Hematologic Malignancies October 16 – 17 2015,USA; Congress of the International Society of Paediatric Oncology Oct 8-9 2015, South Africa;20th World Congress on Advances in Oncology, October 8-10 2015,Greece; Combination Therapies in Cancer Conference: Tools and Techniques for Developing Combinations More Efficiently Dec 06- 09 2015, UK;12^th Cancer Conferences Europe September 26-28, 2016 London, UK;12^th Oncology Conferences Europe September 26-28, 2016 London, UK; 12^th Cancer Science Events Europe September 26-28, 2016 London, UK;  Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE;  Oncology Conferences November 21-23, 2016 Dubai, UAE;  Worldwide Cancer Events November 21-23, 2016 Dubai, UAE;  Breast Cancer Conferences October 03-05, 2016 London, UK;  Women’s Health Conferences October 03-05, 2016 London, UK

Track 13: Hematological Malignancies: Prognosis

The estimate of how the disease will go for a patient is called prognosis. There are many factors affect prognosis that include: the type of cancer and where it is in the body, the stage of the cancer, the cancer’s grade. Grade provides clues about how quickly the cancer is likely to grow and spread certain traits of the cancer cells, the age and how healthy body was before cancer & how successful is the treatment.

Related Conferences :Cancer Diagnostics Conference & Expo June 13-15 2016,Italy ; International Conference on Internal Medicine November 03-05, 2016 ,USA ; 4^th International Conference on Blood Malignancies & Treatment April 18-20 2016,UAE ; Blood Cancer Conference ; International Conference on Leukemia and Bone marrow Transplantation Nov 10-12 2016, Turkey ; 7^th International conference on Biomarkers & Clinical Research November 28-30 2016,USA ; 8^th Euro Global Summit on Cancer Therapy November 03-05 2015,Spain; 9th Indo Global Summit on Cancer Therapy, November 02-04, 2015 Hyderabad, India; Children Vaccines Conference 2016 Oct 10-12, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016, USA; Cancer Genome February 7-11, 2016; VI Inter American Oncology Conference 'Current Status and Future of Therapies’, October 8-9^th, 2015;Fourth AACR International Conference on Frontiers in Basic Cancer Research October 23 – 26 2015,Philadelphia ; 2015 Chabner Colloquium: Collaboration in Cancer Drug Trials 26–27 October 2015, United States ; American Society for Clinical Pathology Annual Meeting Oct 28-30 ,USA ; SITC’s 30th Anniversary Annual Meeting & Associated Programs November 4 – 8, 2015,US ; Cancer Diagnostics Conference; San Francisco Nov 16-17 2015 , United States; Cancer and Metabolism September 28 - 30, 2015,UK; Stem Cell Research & Regenerative Medicine Conference,25–26 April 2016,USA;12^th Cancer Conferences Europe September 26-28, 2016 London, UK;12^th Oncology Conferences Europe September 26-28, 2016 London, UK; 12^th Cancer Science Events Europe September 26-28, 2016 London, UK;  Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE;  Oncology Conferences November 21-23, 2016 Dubai, UAE;  Worldwide Cancer Events November 21-23, 2016 Dubai, UAE;  Breast Cancer Conferences October 03-05, 2016 London, UK;  Women’s Health Conferences October 03-05, 2016 London, UK

Track 14: Blood Cancer : Other Aspects

Other features that are related to blood cancer include several other factors. Anaemia is a common side effect of chemotherapy procedures & sometimes blood cancer itself is cause of anaemia. Researches have shown that there is a clear connection between blood cancer and thrombosis, because some of the genetic changes that cause blood cancer also increase the activation of clotting factors. People with cancer are at increased risk of developing these dangerous blood clots. The other risk factors include blood transfusions, lymphatic System defects, exposure to radiation and carcinogenic chemicals.

Socio economic factors &  also serve to play a role in Blood Cancer. Some syndromes that are caused by genetic mutations (abnormal changes) present at birth seem to raise the risk of Blood Cancer.

Related Conferences : Cancer Diagnostics Conference and Expo, June 13-15, 2016, Italy; 4^th International Conference on Blood Malignancies & Treatment April 18-20 2016,UAE ; International Conference on Leukemia and Bone marrow Transplantation Nov 10-12 2016, Turkey ; Blood Cancer Conference ;10^th Global Annual Oncologists Meeting July 11-13 2016, Germany International Conference on Internal Medicine November 03-05, 2016,USA; 7^th International conference on Biomarkers & Clinical Research November 28-30 2016,USA ; 8^th Euro Global Summit on Cancer Therapy November 03-05 2015,Spain; 7^th International Conference on Biomarkers and Clinical Research, November 28-30, 2016, USA;5th International Conference and Exhibition on Pathology May 09-11, 2016, USA; WSMOS Fall Oncology Conference, 30^th October 2015,UK; ASH Meeting 2016; 7th International Hematologic Malignancies Conference: Bridging the Gap February 27-28, 2016, China; ISEH 45th Annual Scientific Meeting 2016 August 25-28, 2016,USA; Cancer Immunotherapy: Immunity and Immunosuppression Meet Targeted Therapies ,Jan 24-28, 2016,Canada; New and Emerging Trends In Oncology 2016,10 Feb-12 Feb 2016, India; Controlling Cancer Summit 2016,17 May-19 May 2016,London, UK; Euro thrombosis Summit 2015 Oct 1-3 2015,Como ; ASH Meeting on Hematologic Malignancies  Sep 17-19 2015,USA; NCCN 21st Annual Conference: Advancing the Standard of Cancer Care March 31-April 2 2015, USA ; Second Annual New Treatments in Oncology March 5 2016, USA; ASH Conference ;12^th Cancer Conferences Europe September 26-28, 2016 London, UK;12^th Oncology Conferences Europe September 26-28, 2016 London, UK; 12^th Cancer Science Events Europe September 26-28, 2016 London, UK;  Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE;  Oncology Conferences November 21-23, 2016 Dubai, UAE;  Worldwide Cancer Events November 21-23, 2016 Dubai, UAE;  Breast Cancer Conferences October 03-05, 2016 London, UK;  Women’s Health Conferences October 03-05, 2016 London, UK

Hematological malignancies are malignant neoplasms ("cancer"), and they are generally treated by specialists in hematology and/or oncology myeloid in origin. It affects the blood, bone marrow, lymph, and lymphatic system, sometimes more than one body part gets affected.  It affects the production and function of your blood cells. Most of these Malignancies start in your bone marrow where blood is produced.  Billions of people are suffering from blood cancers and millions are dying every year across the globe. Blood Malignancies 2016 will be an initiative to find the weapon to fight against the dreadful blood cancers, to protect and save lives. Discussions will be focused on the different types of blood cancers, possibility of early detection and treatment at the advanced stages of these cancers to prolong life.

This conference will witness the fusion of advanced technology in the field of blood malignancy treatment.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Blood Cancer -2016, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Blood Cancer 2016 organizing committee look forward to meet you in Dubai, UAE.

For more details please visit: http://bloodmalignancies.conferenceseries.com/

Importance and Scope

OMICS Group welcomes all the hematologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of the esteemed Blood Cancer 2016. As this will be the best amalgamation of academia and research involving every aspect of Blood Malignancies Treatment. It is open to all types of research methodologies both from academia and industry.  

Blood Cancer 2016 will be the best platform for all the hematologists, oncologists, research scholars, students who are working in this field to exchange their knowledge related to Blood Malignancies and treatment. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability, and quality of life. Experts will explain how a new generation of treatment options gives patients new hope in the fight against blood cancer.

Why Dubai?

Blood Cancer 2016 is going to be held in Dubai, UAE’s most populous city and has emerged as a global city and business hub of the Middle East and South Asia.Dubai was ranked 44th among the world's best financial cities,it was also indicated that Dubai was the world's 27th richest city in 2012. It is also an international financial centre and has been ranked 37th within the top 50 global financial cities and 1st within the Middle East .According to a research report on the future competitiveness of cities, in 2025, Dubai will have moved up to 23rd place overall in the Index..Dubai is located in middle of the world; the major countries surround it, therefore it will prove to be best congregation destination for all the people. Moreover major of the blood malignancies occur in nearby areas i.e. Asia, Africa, and Middle East etc. and most of the researches on blood malignancies is taking place in countries around dubai hence it serves as the suitable and convinent for researchers from nearby countries to gather and communicate together.

Dubai also possess many ancient and modern attractions. Some of them include its landmark building Burj Khalifa, the tallest building in the world. There are plenty of water features including the Dubai Fountain, the world's tallest performing fountain, the Burj Al Arab world's only 7 star hotel. The global village provides excellent cultural entertainment. Other include Bastakia Quarter,Palm Island ,the Dubai Miracle Garden -the world's largest flower garden .Blood Cancer 2016 Conference at Dubai will certainly give a wonderful experience to attendees to explore the beautiful city with gaining knowledge.

Conference Highlights     

• Blood Malignancies    
• Leukaemia
• Myeloma
• Myelodysplastic Syndromes
• Childhood Hematological Cancers
• Blood Cancer : Diagnosis
• Blood Cancer : Causes & Symptoms
• Blood Cancer : Staging
• Blood Cancer : Treatment and Care
• Bone Marrow Transplantation and Surgery
• Immunology of Blood Cancer
• Blood Oncology
• Hematological Malignancies : Prognosis
• Blood Cancer : Other Aspects

Why to attend?

In today's economic climate your business decisions are as crucial as ever. 4^th International Conference on Blood Malignancies and Treatment allow you to maximize your time and marketing dollars while receiving immediate feedback on your new products and services. 4^th International Conference on Blood Cancer and Treatment is organizing an outstanding Scientific Exhibition/Program and anticipates the world's leading specialists involved in Blood Malignancies and Treatment .Your organization will benefit with excellent exposure to the leaders in Blood Malignancies and Treatment. Blood Cancer 2016 is an exciting opportunity to showcase the new technology, the new products of your company, and/or the service your industry may offer to a broad international audience.

Target Audience

Hematologists, oncologists, researchers, students, industrial delegates from Academia and Research along with the industrial professionals from biomedical companies and healthcare sectors.

A Unique Opportunity for Advertisers and Sponsors at this International event.

 http://bloodmalignancies.conferenceseries.com/sponsors.php

Major Associations:

    In UAE

Emirates Medical Association

Emirates Society of Hematology

Dubai Health Authority

Middle East cancer consortium

   In USA

American Cancer Society (ACS)

Lymphoma Research Foundation, USA

Hematology/Oncology Pharmacy Association

National Cancer Institute

National Children’s Leukaemia Foundation, USA

Cancer Research Institute, USA

International Myeloma Foundation

National Cancer Institute (USA)

Association of International Cancer Research

National Children's Leukemia Foundation

Cancer and Leukemia Group B

International Agency for Research on Cancer (IARC)

Childhood Leukemia Foundation

American Society of Haematology

Union for International Cancer Control (UICC)

Prevent Cancer Foundation

American Childhood Cancer Organisation

American Association for Cancer Research (AACR)

    Worldwide

International Fanconi Anemia Registry (IFAR)

Union for International Cancer Control

The Leukaemia and Lymphoma Society of Canada

Cancer Research UK

Indian Association of blood cancer & Allied Diseases

Leukaemia Cancer Society

Armenian Association of Hematology & Oncology

Leukaemia & Blood Cancer New Zealand

Korean Cancer Association

Fanconi Anaemia Australia

Leukaemia Foundation of Australia

Cancer Association of South Africa

Indian Cancer Society

Brazilian Lymphoma & Leukaemia Association

Chronic Myelogenous Leukaemia Society of Canada

Children’s Cancer and Leukaemia Group

Chinese Society of Clinical Oncology

German Cancer Society

Canadian Cancer Sociey

Lymphoma Foundation Canada

Cancer Society of Finland

France Lymphoma Hope

Society for Paediatric Oncology & Hematology

Leukaemia &Blood Cancer, New Zealand

Medical Oncology Group of Australia

Australian & New Zealand Children’s Hematology/Oncology Group

Childhood Cancer Research Group, UK

National Cancer Institute of Argentina

Cancer Society Nepal

   Top Universities in UAE

Al Ghurair University (AGU)

University of Dubai (UD)

Zayed University

American University in Dubai (AUD)

British University in Dubai (BUiD)

American University in the Emirates (AUE)

   Top Universities in USA

Harvard University

Mayo Medical School, US

University of Oxford

University of Cambridge

Stanford University

Cambridge University

Yale University

University of Colorado

St. George’s University

 Emory University

John Hopkins University

University of Maryland, Baltimore

University of California

North-western University, IIlinois

 University of Texas

Massachusetts Institute of Technology (MIT)

Indiana University School of Medicine, Melvin and Bren Simon Cancer Center,

University of Rochester, New York

Carnegie Mellon University, United States of America

University of Pennsylvania, Philadelphia

Cornell University, United States of America

Baylor COLLEGE of medicine US

 Princeton University, US

University of Minnesota Medical Center

University of Auckland-

University of Michigan

University of Melbourne

Columbia University, New York

University of Iowa

Ohio State University, Columbus

Rockefeller University, US

 Top Universities Worldwide

University of Toronto, Canada

Thomas Jefferson University

University of Chicago, Chicago

University of Wisconsin, Madison-

Washington University in St. Louis

Imperial College, London

University of Tokoyo,Japan

National University of Singapore (NUS), Singapore 

Guangxi Medical University, Nanning, China

Indianapolis University “La Sapienza” of Rome, Rome, Italy 

University of Lyon, France

University Of Leeds –

University Of Queensland ,Australia

University of Arizona Cancer Center

University of Utah

 Institute on cancer research ,UK 

The university of Sheffield ,UK

Georgetown University Medical Center

 University of Southampton

University of Pittsburgh

 McMaster University

University Of Florida

Vanderbilt University School of Medicine

Wayne State University School of Medicine

University of Alberta

University Of British Columbia 

University Of Leicester 

 University Of Chester

University of Kentucky

University  of north Durham

 University Of Surrey

 University Of Edinburgh

 University of Glasgow –

 University Of Bordeaux ,France

Oregon Health And Science university

 Knight Cancer Institute

Loyola University Chicago

University OF Louisville

 University of Toledo

Rutgers University

The university of London 

 University Of Calgary

University Of Witaterstrand

University Of Western Sydney ,Australia

University of Melbourne

 University Of South Australia

University Of New South Wales

Monash University ,Australia

University College London 

 University of Milan, Italy

Kyoto university ,Japan

The university of Auckland,NZ

University Of Zurich

National Taiwan University 

The University of  Manchester,UK

Ichan School of medicine, Mount Sinai

 Pondicherry University, India

University of phoenix

Griffith University

University Of Exeter

Crimea State Medical University,Ukriane

 Heidelberg University

 Hackensack University Medical Center

 Kyoto University, Taiwan

 Osaka university,Japan

 Kursk State Medical university, Russia 

Hospitals Associated On Blood Malignancies

In UAE:

    Al Zahra Private Hospital

    Sheikh Khlifa Medical City

    American Hospital Dubai

    Tawam Hospital

    Saudi German Hospital,Dubai

    Emirates Hospital

In USA:

   New York Presbyterian Hospital

   Memorial Sloan Kettering Cancer Center

   Mayo Clinic Rochester

   MD Anderson Cancer Center,Texas

   John Hopkins Hospital, Baltimore

   University of Washington Medical Center

   Massachusetts General Hospital

   UCSF Medical Center

   UCLA Medical Center

   Stanford Hospital

   City of Hope,CA

   University of Colorado Hospital

   Institute of Cancer Research.London

   Dana-Farber Cancer Institute in Boston, USA

   Memorial Sloan Kettering (MSK) Cancer Center, New York City

   Hospitals of the University of Pennsylvania–Penn Presbyterian, Philadelphia

   Cleveland Clinic

   Seidman Cancer Center at UH Case Medical, Cleveland

   University of Colorado Hospital, Denver

   Hackensack University Medical Center – Hackensack, New Jersey

   Georgetown University Medical Center (Washington, D.C.).

   Montefiore Medical Center (New York City)

   The Toledo (Ohio) Hospital. 

   University of Iowa Hospitals and Clinics (Iowa City).

   University of Virginia Medical Center (Charlottesville)

   Yale-New Haven (Conn.) Hospital.

In Europe:

     Leiden University Medical Center

     Royal Cancer Hospital

     King’s College Hospital

    Clatterbridge Center for Oncology

    Northampton General Hospital

    Cambridge University Hospitals

    University Hospital Southhampton

    Central Manchester University Hospitals

    Southend University Hospital

    Kingston Hospitals

    Bradford Hospital

    Institute of Oncology, Ljubljana

    Institut Gustave Roussy, Paris

    Paterson Institute On Cancer Research,UK

    Christie Hospitals

    Wellington Hospital

    Imperial College Hospital

    Curie Institute

    The Royal Marsden Hospital in London, England

In Asia & Pacific:

    University of Tokyo Hospital

    Institute of Medical Sciences, Tokyo

    Cancer Hospital Chinese academy of medical sciences

    National Cancer Center, China

    Kidwai Memorial Institute of Oncology, India

   Apollo Hospitals

   Tata Memorial Hospitals

   Cancer Center Research Institute

   Cancer Institute (WIA)

   Jawaharlal Nehru Cancer Hospital & Research Center

    IstitutoNazienaledeiTumori di Milan, in Milan, Italy

Major Companies On Hematology

           Johnson & Johnson US         

            Pfizer USA

  Merck USA

  Eli Lilly & Co USA

  Abbott Laboratories USA

  Sanofi FRA

  Amgen USA

  Actavis USA

   Bristol-Myers Squibb USA

   Biogen Idec USA

   Celgene USA

   AstraZeneca

   Biocon

   Cadila Health Care

   Cipla

    Roche

    Reckitt benckiser

     Ranbaxy

     Panaeca Biotech Ltd.

     Piramal Healthcare

      Lupin Ltd.

Market analysis report

According to market study, the market of hematological malignancies is expressed to show steady growth rate during the forecast period from 2014 – 2020. This growth is driven by major factors, such as rising prevalence of various diseases and extensive R&D practices are on-going across the globe to bring new and more effective drugs and formulations in the market. Further, due to extensive R&D practices, a number of drugs and formulations are under pipeline studies. New therapy and drugs such as, histone deacetylase (HDAC) inhibitors, immunomodulatory drugs and proteasome inhibitors are under pipeline study and expected to enter in the market during forecast period. These drivers are anticipated to accentuate the growth of the market.

The total global market for hematological disorder drugs and diagnostics in 2012 was estimated at nearly $72.9 billion.  By 2017, the market is expected to reach $99.1 billion, growing at a compound annual growth rate (CAGR) of 6.4% between 2012 and 2017.  The global blood disorders market segment is estimated at $49.3 billion in 2012 and is expected to reach nearly $64.7 billion by 2017.  The major reason for the low growth rate is the expected decline in the annual cost of treating blood disorders and the patent expirations of Lovenox, Plavix, Procrit/Epogen, Aranesp, and Neulasta. In 2010, all these drugs together brought revenue of about $32 billion into the global blood disorders market.) The global market for haematological cancer drugs was estimated to be $18.7 billion in 2012.  By 2017, the market is expected to reach $28.8 billion, growing at a CAGR of 9% between 2012 and 2017.

The North American region is the most dominating market in the world, owing to rapidly growing incidences of lymphoma cancers and rising focus towards R&D for hematological malignancies treatments. For instance, Lymphoma Research Foundation stated that, T-cell lymphomas accounted for approximately 15% of all non-Hodgkin lymphomas in the U.S. every year. On the other hand, Asia-Pacific and RoW region are the most promising markets in the upcoming period, owing to rise in awareness of blood cancers and its chronic impacts along with its treatments. The Research market research report will increase the awareness of current and emerging drugs and technologies for hematological disorders and blood cancers, including hematological disorder therapeutics, chemotherapy, radiation therapy, surgical therapy, immunotherapy, and nutrition therapy. Novartis International AG, GlaxoSmithKline Pharmaceuticals Limited, Roche, Bristol-Myers Squibb, Genmab A/S, Celgene Corporation, and Biogen Idec rule the present market for leukaemia drugs; whereas Ambit Bioscience & Pfizer are expected to capture major share of the market by 2020.

References

http://www.transparencymarketresearch.com/hematological-malignancies-market.html

http://www.bccresearch.com/pressroom/phm/global-market-hematological-disorder-drugs-diagnostics-expected-reach-$64.7-billion-2017

http://www.insightpharmareports.com/Hematological-Cancer/

http://www.marketsandmarkets.com/Market-Reports/chronic-lymphocytic-leukemia-223.html